{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T10:08:59Z","timestamp":1784628539621,"version":"3.55.0"},"reference-count":61,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2016,1,19]],"date-time":"2016-01-19T00:00:00Z","timestamp":1453161600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1041472"],"award-info":[{"award-number":["1041472"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1073858"],"award-info":[{"award-number":["1073858"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1013803"],"award-info":[{"award-number":["1013803"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1091878"],"award-info":[{"award-number":["1091878"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacoepidemiology and Drug"],"published-print":{"date-parts":[[2016,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Purpose<\/jats:title><jats:p>There has been concern regarding the increasing use of opioids and related harm. We present data on opioid utilisation across Australia and consider sociodemographic factors that may affect utilisation rates.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>IMS Health national sales data for over\u2010the\u2010counter (codeine) and prescription opioids (buprenorphine, codeine, dextropropoxyphene, fentanyl, hydromorphone, methadone, morphine, oxycodone, tapentadol and tramadol) were used to estimate total utilisation rates in the community during 2013, mapped to Statistical Local Areas (SLAs) and Remoteness Areas. All opioid amounts were measured in pack sales and milligrammes then converted to oral morphine equivalent milligrammes (OME mg) for comparison across opioids. Data on the demographic characteristics of SLAs were obtained from the ABS (sex and age distribution, income and levels of physical labour) and other sources (number of pharmacies in SLAs) and were included in linear regression analyses.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In 2013, an estimated 10\u2009747\u2009kg (OME) of opioids were sold across Australia, equating to 481 OME mg per person. There was considerable geographic variation in opioid utilisation, with higher rates of use in rural and regional areas. Geographic areas that were less populated, had more men and older people, proportionally more low\u2010income earning households and greater proportions in jobs requiring physical labour had higher utilisation rates.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Substantial geographic variation in opioid utilisation was identified, with areas outside of major cities having higher rates of utilisation of all types of opioids. Prescription monitoring and best practice interventions aimed at improving opioid use need to have a particular focus on areas outside of major cities. Copyright \u00a9 2016 John Wiley &amp; Sons, Ltd.<\/jats:p><\/jats:sec>","DOI":"10.1002\/pds.3931","type":"journal-article","created":{"date-parts":[[2016,1,19]],"date-time":"2016-01-19T08:31:21Z","timestamp":1453192281000},"page":"521-538","source":"Crossref","is-referenced-by-count":73,"title":["The extent and correlates of community\u2010based pharmaceutical opioid utilisation in Australia"],"prefix":"10.1002","volume":"25","author":[{"given":"Louisa","family":"Degenhardt","sequence":"first","affiliation":[{"name":"National Drug and Alcohol Research Centre UNSW  Sydney New South Wales Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasa","family":"Gisev","sequence":"additional","affiliation":[{"name":"National Drug and Alcohol Research Centre UNSW  Sydney New South Wales Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Cama","sequence":"additional","affiliation":[{"name":"National Drug and Alcohol Research Centre UNSW  Sydney New South Wales Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Nielsen","sequence":"additional","affiliation":[{"name":"National Drug and Alcohol Research Centre UNSW  Sydney New South Wales Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Briony","family":"Larance","sequence":"additional","affiliation":[{"name":"National Drug and Alcohol Research Centre UNSW  Sydney New South Wales Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raimondo","family":"Bruno","sequence":"additional","affiliation":[{"name":"School of Medicine University of Tasmania  Hobart Tasmania Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,1,19]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.2009.01982.x"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.5694\/mja10.11450"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)61138-0"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.puhe.2012.04.010"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.3404"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.7326\/m14-2559"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1276"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1136\/ip.2010.029611"},{"issue":"43","key":"e_1_2_9_10_1","first-page":"1487","article-title":"Vital signs: overdoses of prescription opioid pain relievers\u2014United States, 1999\u20132008","volume":"60","author":"Centers for Disease Control and Prevention","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_2_9_11_1","volume-title":"Emergency department trends from DAWN: final estimates 1995\u20132002","author":"Office of Applied Studies\u2014Substance Abuse and Mental Health Services Administration"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/dar.12033"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.2010.tb03911.x"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.2165\/11595890-000000000-00000"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.2165\/11593100-000000000-00000"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.j.pain.0000460357.01998.f1"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000000213"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2012.04005.x"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006605.pub2"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1584.2006.00775.x"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.2105\/ajph.2013.301709"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/dar.12224"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1136\/ip.2010.029611"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.3767"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/1753-6405.12030"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-7843.2009.00494.x"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12446"},{"key":"e_1_2_9_28_1","unstructured":"IMS Health.Australian Pharmaceutical Index: IMS Plus workshop manual Sydney: IMS Health Australia 2009."},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(95)00017-M"},{"key":"e_1_2_9_30_1","unstructured":"Australian Bureau of Statistics.1270055006C184 Postcode 2011 to Statistical Local Area 2011.http:\/\/www.abs.gov.au\/AUSSTATS\/abs@.nsf\/DetailsPage\/1270.0.55.006July%202011?OpenDocument[5 December2015]."},{"key":"e_1_2_9_31_1","unstructured":"Australian Bureau of Statistics.1216.0.15.003 \u2010 Australian Standard Geographical Classification (ASGC) Remoteness Area Correspondences 2006.http:\/\/www.abs.gov.au\/AUSSTATS\/abs@.nsf\/Lookup\/1216.0.15.003Main+Features12006?OpenDocument[5 December 2015]."},{"key":"e_1_2_9_32_1","unstructured":"Australian Bureau of Statistics.1216.0 \u2013 Australian Standard Geographical Classification (ASGC) July2006 http:\/\/www.abs.gov.au\/ausstats\/abs@.nsf\/mf\/1216.0[5 December 2015]."},{"key":"e_1_2_9_33_1","volume-title":"3235.0 Population by Age and Sex, Regions of Australia","author":"Australian Bureau of Statistics","year":"2012"},{"key":"e_1_2_9_34_1","unstructured":"MavenMarketing.List of pharmacies and chemists in Australia. 2014; Available from:http:\/\/www.mavenmarketing.com.au\/list\u2010of\u2010pharmacies\u2010in\u2010australia\/[14th March 2014]"},{"key":"e_1_2_9_35_1","volume-title":"Comparing Opioids: A Guide to Estimating Oral Morphine Equivalents (OME) in Research. NDARC Technical Report No. 329","author":"Nielsen S","year":"2014"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269216311398300"},{"key":"e_1_2_9_37_1","unstructured":"MIMs Australia. MIMs Online. Australia: MIMs.https:\/\/www.mimsonline.com.au\/Search\/Search.aspx[5 December 2015]."},{"key":"e_1_2_9_38_1","volume-title":"ESRI ArcGIS Desktop 10.2","author":"Environmental Systems Research Institute Inc","year":"2013"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010107.pub3"},{"issue":"3","key":"e_1_2_9_40_1","first-page":"236","article-title":"OTC codeine: examining the evidence for and against","volume":"31","author":"Nielsen S","year":"2012","journal-title":"Aust Pharmacist"},{"key":"e_1_2_9_41_1","doi-asserted-by":"publisher","DOI":"10.5694\/mja15.00183"},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001547.pub2"},{"key":"e_1_2_9_43_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa041888"},{"key":"e_1_2_9_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(00)00355-9"},{"key":"e_1_2_9_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2015.02.004"},{"key":"e_1_2_9_46_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-014-0563-8"},{"key":"e_1_2_9_47_1","doi-asserted-by":"publisher","DOI":"10.1080\/00952990601175078"},{"key":"e_1_2_9_48_1","doi-asserted-by":"publisher","DOI":"10.1111\/pme.12773"},{"key":"e_1_2_9_49_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g1251"},{"key":"e_1_2_9_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2014.02.701"},{"key":"e_1_2_9_51_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0080095"},{"key":"e_1_2_9_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2010.08.036"},{"key":"e_1_2_9_53_1","doi-asserted-by":"publisher","DOI":"10.1111\/pme.12907"},{"key":"e_1_2_9_54_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0134550"},{"key":"e_1_2_9_55_1","volume-title":"Australian Drug Trends Series No. 127","author":"Stafford J","year":"2015"},{"key":"e_1_2_9_56_1","volume-title":"A Review of Opioid Prescribing in Tasmania: A Blueprint for the Future","author":"Mattick RP","year":"2012"},{"key":"e_1_2_9_57_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/97.8.554"},{"key":"e_1_2_9_58_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10935-014-0381-0"},{"key":"e_1_2_9_59_1","doi-asserted-by":"publisher","DOI":"10.4137\/SART.S2345"},{"key":"e_1_2_9_60_1","doi-asserted-by":"publisher","DOI":"10.1111\/dar.12066"},{"key":"e_1_2_9_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2015.06.001"},{"key":"e_1_2_9_62_1","doi-asserted-by":"publisher","DOI":"10.1111\/dar.12279"}],"container-title":["Pharmacoepidemiology and Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpds.3931","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpds.3931","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pds.3931","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T11:43:33Z","timestamp":1696506213000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pds.3931"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,19]]},"references-count":61,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["10.1002\/pds.3931"],"URL":"https:\/\/doi.org\/10.1002\/pds.3931","archive":["Portico"],"relation":{},"ISSN":["1053-8569","1099-1557"],"issn-type":[{"value":"1053-8569","type":"print"},{"value":"1099-1557","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,19]]}}}